Abstract
The efferent vagus nerve can regulate inflammation via its principal neurotransmitter acetylcholine (ACh), a concept referred to as the 'cholinergic anti-inflammatory pathway'. ACh interacts with members of the nicotinic acetylcholine receptor (nAChR) family, in particular with the α7 subunit (α7nAChR), which is expressed not only by neurons but also macrophages and other cells involved in the inflammatory response. In these inflammatory cells, the stimulation of α7nAChR by ACh and other α7nAChR-specific agonists suppresses the release of proinflammatory cytokines. Recent work has suggested that α7nAChR could represent a new target for the treatment of rheumatic diseases. In this Perspective, we describe the cholinergic anti-inflammatory pathway and the therapeutic potential of modulating this pathway in rheumatoid arthritis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Steinman, L. Elaborate interactions between the immune and nervous systems. Nat. Immunol. 5, 575–581 (2004).
Tracey, K. J. The inflammatory reflex. Nature 420, 853–859 (2002).
Borovikova, L. V. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458–462 (2000).
van der Zanden, E. P., Boeckxstaens, G. E. & de Jonge, W. J. The vagus nerve as a modulator of intestinal inflammation. Neurogastroenterol. Motil. 21, 6–17 (2009).
Borovikova, L. V. et al. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton. Neurosci. 85, 141–147 (2000).
Wang, H. et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421, 384–388 (2003).
The, F. O. et al. Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice. Gastroenterology 133, 1219–1228 (2007).
van Westerloo, D. J. et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130, 1822–1830 (2006).
Giebelen, I. A., van Westerloo, D. J., Larosa, G. J., de Vos, A. F. & van der Poll, T. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 28, 700–703 (2007).
van Maanen, M. A. et al. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum. 60, 114–122 (2009).
Waldburger, J. M., Boyle, D. L., Pavlov, V. A., Tracey, K. J. & Firestein, G. S. Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor. Arthritis Rheum. 58, 3439–3449 (2008).
van Maanen, M. A. et al. The alpha 7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients. Arthritis Rheum. (in press).
Stojanovich, L. et al. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjogren syndrome and other autoimmune diseases. Lupus 16, 181–185 (2007).
Goldstein, R. S. et al. Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol. Med. 13, 210–215 (2007).
de Jonge, W. J. & Ulloa, L. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br. J. Pharmacol. 151, 915–929 (2007).
Drisdel, R. C. & Green, W. N. Neuronal alpha-bungarotoxin receptors are alpha7 subunit homomers. J. Neurosci. 20, 133–139 (2000).
de Jonge, W. J. et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat. Immunol. 6, 844–851 (2005).
Walker, J. G. & Smith, M. D. The Jak-STAT pathway in rheumatoid arthritis. J. Rheumatol. 32, 1650–1653 (2005).
Wang, H. et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10, 1216–1221 (2004).
Villiger, Y. et al. Expression of an alpha7 duplicate nicotinic acetylcholine receptor-related protein in human leukocytes. J. Neuroimmunol. 126, 86–98 (2002).
Guarini, S. et al. Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock. Circulation 107, 1189–1194 (2003).
Zhang, P., Han, D., Tang, T., Zhang, X. & Dai, K. Inhibition of the development of collagen-induced arthritis in Wistar rats through vagus nerve suspension: a 3-month observation. Inflamm. Res. 57, 322–328 (2008).
Shafique, S. & Dalsing, M. C. Vagus nerve stimulation therapy for treatment of drug-resistant epilepsy and depression. Perspect. Vasc. Surg. Endovasc. Ther. 18, 323–327 (2006).
Carlens, C., Brandt, L., Klareskog, L., Lampa, J. & Askling, J. The inflammatory reflex and risk for rheumatoid arthritis: a case-control study of human vagotomy. Ann. Rheum. Dis. 66, 414–416 (2007).
Levin, E. D. & Rezvani, A. H. Development of nicotinic drug therapy for cognitive disorders. Eur. J. Pharmacol. 393, 141–146 (2000).
Huang, X., Zheng, F., Stokes, C., Papke, R. L., Zhan, C. G. Modeling binding modes of alpha7 nicotinic acetylcholine receptor with ligands: the roles of Gln117 and other residues of the receptor in agonist binding. J. Med. Chem. 51, 6293–6302 (2008).
Kitagawa, H. et al. Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. Neuropsychopharmacology 28, 542–551 (2003).
Huston, J. M. et al. Splenectomy inactivates the cholinergic anti-inflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 203, 1623–1628 (2006).
Rosas-Ballina, M. et al. Splenic nerve is required for cholinergic anti-inflammatory pathway control of TNF in endotoxemia. Proc. Natl Acad. Sci. USA 105, 11008–11013 (2008).
Pavlov, V. A. et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav. Immun. 23, 41–45 (2009).
Birks, J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD005593. doi:0.1002/14651858.CD005593.
Wessler, I. & Kirkpatrick, C. J. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br. J. Pharmacol. 154, 1558–1571 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
van Maanen, M., Vervoordeldonk, M. & Tak, P. The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. Nat Rev Rheumatol 5, 229–232 (2009). https://doi.org/10.1038/nrrheum.2009.31
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2009.31
This article is cited by
-
Cholinergic anti-inflammatory pathway and connective tissue diseases
Inflammopharmacology (2021)
-
Downregulation of α7 nicotinic acetylcholine receptors in peripheral blood monocytes is associated with enhanced inflammation in preeclampsia
BMC Pregnancy and Childbirth (2019)
-
Noninvasive ultrasound stimulation of the spleen to treat inflammatory arthritis
Nature Communications (2019)
-
Recent advances in cyclosporine drug delivery: challenges and opportunities
Drug Delivery and Translational Research (2019)
-
Optimizing stimulus waveforms for electroceuticals
Biological Cybernetics (2019)